Found 465 matching trials
PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale Cancers, PERCEIVE-II
N/AThis study is a prospective study aimed to validate the performance of comb...
Location
Fudan university shanghai cancer center, Deparment of gynecologic oncology
Comparison of Whole-body MRI, Circulating DNA and PET-CT in Staging, Prognosis, and Treatment Response in Patients with Diffuse Large Cell B Lymphoma
N/AThe aim of the study is to compare the diagnostic performance of whole-body...
Location
Department of Radiology, General University Hospital in Prague, Prague, Czech Republic
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)
N/AThe purpose of this study is to enable non-invasive early detection of ovar...
Location
The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence
N/ATo prospectively collect blood and tumor tissue from esophageal cancer pati...
Location
Mayo Clinic in Rochester
LAMBDA 002 (Lung Registry) Study
N/AThe LAMBDA 002 registry study is an observational, longitudinal, multi-cent...
Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma.
N/ACirculating free cell DNA (cfDNA) is extracellular fragmentation of nucleic...
Location
Stanford Genome Technology Center
Colon Cancer Liquid Biopsy Investigation of Methylation-based Biomarkers Evaluation Using Delta-HLD (CLIMBED)
N/ACLIMBED (Colon cancer Liquid biopsy Investigation of Methylation-based Biom...
Methylated DNA Detect in Paraneoplastic Syndrome of Nervous System
N/AThe purpose of this study is to verify whether the cell-free DNA of lung ca...
Location
Peking University Third Hospital
Circulating and Imaging Biomarkers to Improve Lung Cancer Management and Early Detection
N/AValidation of biomolecular markers in the circulation and radiomic features...
Location
Istituto Clinico Humanitas
Immune Monitoring to Facilitate Belatacept Monotherapy
PHASE4* To determine the utility of novel blood-based immune monitoring tools (Al...
Location
Massachusetts General Hospital